People · Operator
Named in public records as an officer, director or promoter · active 2008–2019 · Biotechnology, Other, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cognition Therapeutics Inc | — | Biotechnology | Series B | $34.9M | $65.4M | 2012 |
| Nor1 Inc | — | Other | Series A | $27.3M | $181.6M | 2008 |
| CytoSite BioPharma Inc. | — | Biotechnology | Series A | $7.1M | $92.2M | 2018 |
| JRST, Inc. | — | Other Energy | Pre-Seed | $816K | $7.1M | 2010 |
Robert Gailus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Gailus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Smith | 1 | 11 |
| John Pasquesi | 1 | 6 |
| Franz Hefti | 1 | 6 |
| Aaron Fletcher | 1 | 5 |
| Brian Barth | 1 | 4 |
| James Jenson | 1 | 3 |
| Steve Angel | 1 | 2 |
| Irwin Scher | 1 | 2 |
| Peggy Wallace | 1 | 2 |
| Stephen Sands | 1 | 2 |
| Robert Kirk | 1 | 2 |
| Franz F. Hefti | 1 | 2 |
| Barry Padgett | 1 | 2 |
| Kenneth I. Moch | 1 | 2 |
| Thomas Thornhill | 1 | 1 |
| Vann Avedisian | 1 | 1 |
| Mark Holtzman | 1 | 1 |
| Tom Christopoul | 1 | 1 |
| Rob Kline | 1 | 1 |
| Jason Bryant | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.